STOCK TITAN
  1. Home
  2. Sec-filings
  3. DARE
  4. [Form 4] Dare Bioscience, Inc. Insider Trading Activity

Dare Bioscience (DARE) director receives 26,540 RSUs in lieu of cash fees

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Steele Robin Joan reported acquisition or exercise transactions in this Form 4 filing.

Dare Bioscience director Robin Joan Steele received an equity grant instead of cash fees for board service. She was awarded 26,540 restricted stock units, each representing one share of common stock when vested, at a stated price of $0.00 per unit. Following this grant, she directly holds 47,055 shares, including the new RSUs. The RSUs vest on January 4, 2027, aligning her compensation more closely with Dare Bioscience’s long-term share performance.

Positive

  • None.

Negative

  • None.
Insider Steele Robin Joan
Role null
Type Security Shares Price Value
Grant/Award Common stock 26,540 $0.00 --
Holdings After Transaction: Common stock — 47,055 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSUs granted 26,540 shares Restricted stock units granted for board and committee service
Price per RSU $0.00 per share Grant price stated for RSU award
Shares after transaction 47,055 shares Total Dare Bioscience shares held directly after RSU grant
RSU vesting date January 4, 2027 Date on which granted RSUs are scheduled to vest
restricted stock units ("RSU") financial
"Represents shares underlying restricted stock units ("RSU") granted to the reporting person"
in lieu of cash compensation financial
"RSU granted to the reporting person in lieu of cash compensation for service"
board of directors financial
"cash compensation for service on the issuer's board of directors and its committees"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
vests financial
"Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Steele Robin Joan
(Last)(First)(Middle)
3655 NOBEL DRIVE
SUITE 260
(Street)
SAN DIEGO CALIFORNIA 92122
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Dare Bioscience, Inc. [ DARE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock06/30/2026A26,540(1)A$047,055D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares underlying restricted stock units ("RSU") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027.
Remarks:
/s/ Sabrina Martucci Johnson, Attorney-in-fact07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Dare Bioscience (DARE) report for Robin Joan Steele?

Dare Bioscience reported that director Robin Joan Steele received 26,540 restricted stock units as compensation for board and committee service. Each RSU converts into one common share upon vesting, aligning her pay with the company’s future stock performance rather than immediate cash.

How many Dare Bioscience (DARE) shares does Robin Joan Steele hold after this grant?

After the grant, Robin Joan Steele directly holds 47,055 Dare Bioscience shares, including shares underlying the new restricted stock units. This figure reflects her updated equity position as reported in the Form 4 insider transaction filing with the SEC.

What are the terms of the 26,540 RSUs granted by Dare Bioscience (DARE)?

The 26,540 restricted stock units each represent a contingent right to receive one Dare Bioscience common share when vested. The filing states a grant price of $0.00 per share equivalent, consistent with stock-based compensation awards for board service rather than market purchases.

When do Robin Joan Steele’s Dare Bioscience (DARE) RSUs vest?

The restricted stock units granted to Robin Joan Steele vest on January 4, 2027. Vesting means she will then be entitled to receive one share of Dare Bioscience common stock for each RSU, subject to the award’s standard service-based conditions.

Why did Dare Bioscience (DARE) grant RSUs instead of cash to Robin Joan Steele?

The filing explains that the 26,540 RSUs were granted in lieu of cash compensation for service on the board and its committees. This structure shifts a portion of director pay into equity, tying compensation to Dare Bioscience’s stock over time rather than immediate cash payments.